A comprehensive examination of the roles played by all participants has the potential to produce faster and more concrete results, leading to improved patient outcomes.
TORONTO (PRWEB) March 17, 2021
Every drug development program must begin with a thorough identification of all relevant stakeholders — patients, physicians, regulators, investors — and an understanding of how they factor into the development process. It’s not just a matter of courtesy; a comprehensive examination of the roles played by all participants has the potential to produce faster and more concrete results, leading to improved patient outcomes.
Register for this webinar to learn about these and other vital product development considerations, such as:
- Developing a framework for handling multiple endpoints for the drug’s go-to-market label
- Determining the potential of adaptive design for optimizing the trial and evaluating the applicability of various adaptive design approaches
- Key interactions and questions to ask when seeking regulatory input of pivotal study designs
Join expert speakers from Premier Research, Abie Ekangaki, Ph.D., Vice President, Statistical Consulting and Rupa Doshi, Executive Director, Program Strategy – Oncology in a live webinar on Wednesday, April 7, 2021 at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Considerations to Improve Patient Outcomes in Early Drug Development.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.